glp-1 binge eating receptor agonists reduce symptoms in systematic review | Ilaria Costantini posted on the topic New Insight: GLP‑1 medications—long used

6-12 months after treatment, most participants showed improvement in insulin production markers and could maintain those levels consistently

Skin lightening creams and intravenous or oral glutathione do not offer reasonable clinical benefit over placebo effect, are not associated with long term improvements, harbor potential adverse events (heavy metal toxicity and renal injury) or lack safety data (intravenous glutathione) and hence, not recommended (98100)

10.1016/j.mehy.2015.06.027 Med

Redness or irritation can occur

For researchers comparing peptides in the UK, Ipamorelin is often reviewed alongside purity testing, batch traceability, Certificates of Analysis and supplier transparency